List of cocaine analogues
This is a list of cocaine analogues. A cocaine analogue is a artificial construct of a novel chemical compound from cocaine's molecular structure, with the result product sufficiently similar to cocaine to display similarity in, but alteration to, its chemical function. Within the scope of analogous compounds created from the structure of cocaine, so named "cocaine analogues" retain 3β-benzoyloxy or similar functionality on a tropane skeleton, as compared to other stimulants of the kind. Many of the semi-synthetic cocaine analogues proper which have been made & studied have consisted of among the nine following classes of compounds:
- stereoisomers of cocaine
- 3β-phenyl ring substituted analogues
- 2β-substituted analogues
- N-modified analogues of cocaine
- 3β-carbamoyl analogues
- 3β-alkyl-3-benzyl tropanes
- 6/7-substituted cocaines
- 6-alkyl-3-benzyl tropanes
- piperidine homologues of cocaine
Analogs ''sensu stricto''">Structural analog#Chemistry">Analogs ''sensu stricto''
Cocaine Stereoisomers
Stereoisomer | S. Singh's alphanumeric assignation | IC50 tritium|WIN 3542 inhibition to rat striatal membranes Mean error standard ≤5% in all cases | IUPAC nomenclature |
R-cocaine | — | 102 | methyl-3--8-methyl-8-azabicyclooctane-2-carboxylate |
R-pseudococaine | 172 | 15800 | methyl-3--8-methyl-8-azabicyclooctane-2-carboxylate |
R-allococaine | 173 | 6160 | methyl-3--8-methyl-8-azabicyclooctane-2-carboxylate |
R-allopseudococaine | 174 | 28500 | methyl-3--8-methyl-8-azabicyclooctane-2-carboxylate |
S-cocaine | 175 | 15800 | methyl-3-oxy-8-methyl-8-azabicyclooctane-4-carboxylate |
S-pseudococaine | 176 | 22500 | methyl-3-oxy-8-methyl-8-azabicyclooctane-4-carboxylate |
S-allococaine | 177 | 9820 | methyl-3-oxy-8-methyl-8-azabicyclooctane-4-carboxylate |
S-allopseudococaine | 178 | 67700 | methyl-3-oxy-8-methyl-8-azabicyclooctane-4-carboxylate |
Where the 2D diagrams given for the structural analogs below do not indicate stereochemistry, it should be assumed they share the conformation of R-cocaine, unless noted otherwise.
The natural isomerism of cocaine is unstable in several ways besides having a high degree of lability; for instance: the C2 carbomethoxy in its biosynthesis end-product maintains the axial position, which can undergo epimerization via saponification to obtain the former in an equatorial position.
The creation of the following analogues of cocaine have traditionally required a step which has utilized 2-CMT as an intermediate molecular product.
Benzoyl branch cleavage substitutions (excluding the exhaustive phenyl group)
product of aspirin used to make salbutamol. It is relevant to the precursor here though because the migrated acetyl group can be the subject of a haloform reaction. A more direct route to vanillic acid though is just oxidation of the vanillin to a functionalized benzoic acid.Arene benzene-ring">Aromatic hydrocarbon">Arene benzene-ring 2′, 3′, 4′ (5′ & 6′) position ([aryl]) substitutions
''para''-substituted benzoylmethylecgonines
Structure | S. Singh's alphanumeric assignation | 4′=R | DAT WIN 35428 | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
H | 249 ± 37 | 615 ± 120 | 2500 ± 70 | 2.5 | 10.0 | ||
non-benzoyloxy analogue comparative ligands | 11b | F — — | 24 ± 4 775 ± 20 5200 ± 1270 | 690 ± 14 762 ± 90 15 ± 3 | 258 ± 40 135 ± 21 963 ± 158 | 28.7 1.0 0.003 | 10.7 0.2 0.2 |
- | - | - | - | - | - | - | |
183a | I | 2522 ± 4 | 1052 ± 23 | 18458 ± 1073 | 0.4 | 7.3 | |
183b | Ph | 486 ± 63 | - | - | - | - | |
183c | OAc | 144 ± 2 | - | - | - | - | |
183d | OH | 158 ± 8 | 3104 ± 148 | 601 ± 11 | 19.6 | 3.8 | |
F | - | - | - | - | - | ||
NCS | - | - | - | - | - |
The MAT binding pocket analogous to the lipophilic place on cocaine-like compounds, inclusive of the benzene ring, is approximate to 9 Å in length. Which is only slightly larger than a phenyl ring by itself.
''meta''-substituted benzoylmethylecgonines
Structure | S. Singh's alphanumeric assignation | 3′=R | DAT WIN 35428 | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
- | - | - | - | - | - | - | |
184a | I | 325ɑ | - | - | - | - | |
184b | OH | 1183 ± 115 | 793 ± 33 | 3760 ± 589 | 0.7 | 3.2 | |
191 | OBn | - | - | - | - | - | |
NCS | - | - | - | - | - |
- ɑIC50 value for displacement of cocaine
''ortho''-substituted benzoylmethylecgonines
Structure | S. Singh's alphanumeric assignation | 2′=R | DAT WIN 35428 | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
- | - | - | - | - | - | - | |
185a | I | 350ɑ | - | - | - | - | |
185b | F | 604 ± 67 | 1770 ± 309 | 1392 ± 173 | 2.9 | 2.3 | |
185c | OAc | 70 ± 1 | 219 ± 20 | 72 ± 9 | 3.1 | 1.0 | |
185d | OH | 25 ± 4 | 143 ± 21 | 48 ± 2 | 5.7 | 1.9 |
- ɑIC50 value for displacement of cocaine
manifold benzoyloxy phenyl-substitutions
For an exposition & allusion to this mechanism observe that the opioid oxycodone, derived from codeine, is 1.5×—1.7× the analgesic potency of morphine ; yet oxycodone's intermediates in its synthesis from codeine are: ⅓ the potency of codeine ; 0.13 that of morphine in rats and less in mice ; with the final possible stand alone intermediate compound between codeine & oxycodone being at most 150% to 200% that of codeine.
Structure | S. Singh's alphanumeric assignation | ortho-2′=R | meta-3′=R | para-4′=R | DAT WIN 35428 | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
186 | HO | H | I | 215 ± 19 | 195 ± 10 | 1021 ± 75 | 0.9 | 4.7 | |
H | OCH3 | OH | - | - | - | - | - |
benzoyl phenyl-alterations
The naphthalene analogs allow for further numeric substitutions, including eight position peri substituted patterns. Many more alterations creating differing aromatic rings are possible.Structure | S. Singh's alphanumeric assignation | C=R | DAT Cocaine | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
187 | 1-naphthalene | 742 ± 48 | - | - | - | - | |
188 | 2-naphthalene | 327 ± 63 | - | - | - | - |
Benzoyl branch modifications
A sulfur in place of the oxygen at the benzoyl ester single bond results in a lower electronegativity than that of cocaine.C1-tropane-ring hydrogen—substitutions
cf. hydroxytropacocaine for a natural alkaloid that is a C1 substituent with a hydroxy group.Structure | Trivial name | R | Ki @ DAT | Ki @ SERT | Ki @ NET | σ1 affinity Ki | σ2 affinity Ki | IC50 Na+ inhibition c | LogP |
-Cocaine | H | 326 ± 106 | 513 ± 143 | 358 ± 69 | 6.7 ± 0.3 μMd | "significant" | 6.99 ± 2.43 | 2.30 | |
-1-methyl-cocaine | Me | 163 ± 23 | 435 ± 77 | 488 ± 101 | "unappreciable" | 1.13 μM | 16.01 ± 1.90 | 2.67 | |
-1-ethyl-cocaine | Et | 95.1 ± 17.0ɑ | 1,106 ± 112 | 598 ± 179 | — | — | — | 3.20 | |
-1-n-propyl-cocaine | n-Pr | 871 ± 205ɑ | 2,949 ± 462b | 796 ± 195 | — | — | — | 3.56 | |
-1-n-pentyl-cocaine | n-C5H11 | 1,272 ± 199b | 1,866 ± 400ɑ | 1,596 ± 21b | — | — | — | 4.64 | |
-1-phenyl-cocaine | Ph | 32.3 ± 5.7b | 974 ± 308 | 1,980 ± 99b | 524 nM | 198 nM | 0.29 ± 0.07 | 3.77 |
- ɑ, P < 0.05 compared with -cocaine
- b, P < 0.01 compared with -cocaine
- cLidocaine was found to have a value of 39.6 ± 2.4, the weakest of all tested.
- dSame reference gives 25.9 ± 2.4 μM for -cocaine and 13.6 ± 1.3 μM for norcocaine. Comparably it gives 12.7 ± 1.5 μM for the sigmaergic affinity of -amphetamine. Another reference gives 1.7-6.7 μM for -cocaine. All values Ki.
- Using same data-set as above table, the following compounds were found to compare as:
- *CFT @ DAT = 39.2 ± 7.1
- *fluoxetine @ SERT = 27.3 ± 9.2
- *desipramine @ NET = 2.74 ± 0.59
The C1 phenyl analog is ten times stronger than cocaine as a dopamine reuptake pump ligand, and twenty four times stronger as a local anesthetic, whereas the C1 methyl analog is 2.3 times less potent as a local anesthetic.
2''β''-substitutions (including transesterification metabolite substitution cocaethylene)
The consideration that large, bulky C2 substituents would alter the tropane by distorting the piperidine ring part of its skeleton sufficiently enough to impair its functionality, or that in said event such would hamper binding, in particular at the 8-aza end to ease steric strain going toward its place from the 2-position, appear to in many cases be unfounded..
Compound 197b displayed a 1,131-fold increased selectivity in affinity over the serotonin transporter, with only slight reductions in potency for the dopamine & norepinephrine transporters. Whereas 197c had a 469× increase at SERT, with greater affinity for DAT than cocaine & was approximately equipotent to NET. 197b was 137×, and 196c 27× less potent at binding to the serotonin transporter, but both had a NET / DAT ratio that made for a better dopaminergic than cocaine.
Structure | S. Singh's alphanumeric assignation | R | DAT WIN 35428 | 5-HTT Paroxetine | NET Nisoxetine | Selectivity 5-HTT/DAT | Selectivity NET/DAT |
- | - | - | - | - | - | - | |
Me | 89 ± 4.8 | 1045 ± 89 | 3298 ± 293 | 11.7 | 37.0 | ||
196a | Et | 195 ± 45 | 5801 ± 493 | 10000 ± 751 | 29.7 | 51.3 | |
196b | n-Pr | 196 ± 46 | 4517 ± 430 | 6124 ± 262 | 23.3 | 31.2 | |
196c | i-Pr | 219 ± 48 | 25224 ± 1498 | 30384 ± 1685 | 115 | 139 | |
196d | Ph | 112 ± 31 | 33666 ± 3330 | 31024 ± 1909 | 300 | 277 | |
196e | Bn | 257 ± 14 | 302 ± 23 | 20794 ± 950 | 1.2 | 80.9 | |
196f | β-phenethyl | 181 ± 10 | 615 ± 52 | 19944 ± 1026 | 3.4 | 110 | |
196g | γ-phenylpropyl | 147 ± 19 | 374 ± 15 | 4893 ± 344 | 2.5 | 33.3 | |
196h | cinnamyl | 371 ± 15 | 368 ± 6.3 | 68931 ± 3476 | 1.0 | 186 | |
196i | p-NO2-β-phenethyl | 601 ± 28 | - | - | - | - | |
196j | p-Cl-β-phenethyl | 271 ± 12 | - | - | - | - | |
196k | p-NH2-β-phenethyl | 72 ± 7 | - | - | - | - | |
196l | p-NCS-β-phenethyl | 196 ± 14 | - | - | - | - | |
196m | p-azido-β-phenethyl | 227 ± 19 | - | - | - | - | |
196n | β-phenethyl | 61 ± 6 | - | - | - | - | |
196o | β-phenethyl | 86 ± 4 | - | - | - | - | |
197a | NH2 | 753 ± 41.3 | 13725 ± 1256 | 3981 ± 229 | 18.2 | 5.3 | |
197b | -NMe2 | 127 ± 6.36 | 143713 ± 8854 | 7329 ± 158 | 1131 | 57.7 | |
197c | -NMe | 60 ± 6.4 | 28162 ± 2565 | 3935 ± 266 | 469 | 65.6 | |
197d | -NHMe | 2424 ± 118 | 44798 ± 2105 | 4213 ± 206 | 18.5 | 1.7 | |
197e | -OH | 195000 | - | - | - | - | |
197f | HOCH2- | 561 ± 149 | - | - | - | - | |
197g | H | 5180 ± 1160 | - | - | - | - |
[Bioisostere] 2-position carbmethoxy-ester functional replacements
Benzoylecgonine, i.e. compound 197e, has an extreme loss in potency as displayed by in vitro methodologies for determining binding efficacy and is posited to be due possibly to zwitterion formation.Structure | S. Singh's alphanumeric assignation | R | Mazindol | DA | Selectivity Uptake/Binding |
580 ± 70 | 570 ± 180 | 1.0 | |||
- | - | - | - | - | |
198a | H | 520 ± 40 | 260 ± 70 | 0.5 | |
198b | CO2Et | 120 ± 10 | 290 ± 40 | 2.4 | |
198c | BOC | 2230 ± 220 | 1820 ± 810 | 0.8 | |
198d | Ph | 2000 ± 640 | 2920 ± 1620 | 1.5 | |
198e | CH=CHCO2Me | 3600 ± 400 | 3590 ± 1180 | 1.0 | |
- | - | - | - | - |
File:2-_cocaine_analogue.png|thumb|right|x180px|2-
File:D3-methyl cocaine.svg|thumb|
Structure | S. Singh's alphanumeric assignation | R | Mazindol | DA | Selectivity Uptake/Binding |
- | - | - | - | - | |
199a | βCO2Et | 710 ± 150 | 1060 ± 340 | 1.5 | |
199b | αCO2Et | 5830 ± 630 | 8460 ± 620 | 1.4 |
Structure | S. Singh's alphanumeric assignation | R | Mazindol | DA | Selectivity Uptake/Binding |
200 | 880 ± 350 | 400 ± 140 | 0.4 |
Vinylogous 2''β''-position carbmethoxy-ester functional replacements
201b & 201c show significant increased potency over cocaine; whereas 201a, 201d & 201e are considerably less so. This infers the hydrogen bond acceptor at the 2β position to not necessarily be of exclusive import in creation of higher binding analogues of cocaine.File:D5-phenyl cocaine.svg|thumb|
Structure | S. Singh's alphanumeric assignation | R | Mazindol | DA | Selectivity Uptake/Binding |
- | - | - | - | - | |
201a | H | 1730 ± 550 | 1120 ± 390 | 0.6 | |
201b | Cl | 222 ± 49 | 368 ± 190 | 1.6 | |
201c | CO2Et | 50 ± 10 | 130 ± 10 | 2.6 | |
201d | CH=CHCO2Et | 1220 ± 100 | 870 ± 50 | 0.7 | |
201e | PO2 | 4850 ± 470 | 5500 ± 70 | 1.1 |
''N''-modifications
Compound | S. Singh's alphanumeric assignation | N8-R | Mazindol binding | DA uptake | Selectivity Uptake/Binding |
217 | - | 10700 ± 1530ɑ | - | - | |
CH3 | 280 ± 60 102ɑ | 320 ± 10 | 1.1 | ||
218 | H | 303 ± 59ɑ | - | - | |
219a | Bn | 668 ± 67ɑ | - | - | |
219b | Ac | 3370 ± 1080ɑ | - | - | |
219c | CH2CH2OH | 700 ± 100 | 1600 ± 200 | 2.3 | |
219d | CH2CO2CH3 | 480 ± 40 | 1600 ± 100 | 3.3 | |
219e | CH2CO2H | 380 ± 20 | 2100 ± 400 | 5.5 | |
220a | SO2CH3 | 1290 ± 80 | 1970 ± 70 | 1.5 | |
220b | SO2CF3 | 330 ± 30 | 760 ± 20 | 2.3 | |
220c | SO2NCO | 120 ± 10 | 160 ± 10 | 1.3 | |
220d | SO2Ph | 20800 ± 3500 | 61000 | 2.9 | |
220e | SO2C6H4-4-NO2 | 5720 ± 1140 | 18800 ± 90 | 3.3 | |
220f | SO2C6H4-4-OCH3 | 6820 ± 580 | 16400 ± 1400 | 2.4 | |
221a | NO | 99500 ± 12300 | 231700 ± 39500 | 2.3 | |
221b | NO2 | 7500 ± 900 | 21200 ± 600 | 2.8 | |
221c | NHCOCH3 | >1000000 | >1000000 | - | |
221d | NH2 | - | - | - |
- ɑIC50 for displacement of WIN 35428
Bridged (''N''-constrained/tethered) tropane-fused cocaine analogues
8 to 2 position tropane bridge
Compound | S. Singh's alphanumeric assignation | R | Mazindol | DA | Selectivity Uptake/Binding |
222 | 44900 ± 6200 | 115000 ± 15700 | 2.6 |
Back-bridged cocaine analogues are considered more akin to untethered cocaine analogs & phenyltropane derivatives and better mimics their affinities. This is due to when the eighth carbon tropane position is freely rotatable and unbound it preferably occupies the axial position as defining its least energy & most unhindered state. In front-bridged analogs the nitrogen lone pairings rigid fixity makes it reside in an equatorial placing for the piperidine ring-part of the tropane nucleus, pointing to the two-carbon & three methylene unit bridgehead; giving the attested front-bridged cocaine analogues preference for SERT over DAT.
Tricyclic cocaine analogues
Tethering the nitrogen 8 tropane position one position further and linking all the way across to the 3β aryl, replacing it; yields an expansive front-bridged structure to create a structurally tricyclic series of cocaine analogues.8 to 3 position
Compound | X | Y | R | SERT Ki | DAT Ki | NET Ki |
1 | Cl | Cl | CH2OCOMe | 1.6 | 1870 | 638 |
2 | Br | Cl | CO2Me | 2.3 | 5420 | 459 |
3 | I | Cl | CH2OCOPh | 0.06 | >10K | >10K |
Azabornane tropane ring contraction
Alterations shortening the tropane ring system while including the benzoyloxy length at the C3 have been made, contrasting the azabornane phenyltropanes; likely remedying the shallow penetration of the latter.5-benzoatic & 6-benzoatic
Comparison of tropane ring versus the norbornane in overlay, with contrast of benzoyl branch in its configuration of how it lays extended out from body of either main ring type
6/7 tropane position methoxycocaine & methoxypseudococaine analogues
Compound | S. Singh's alphanumeric assignation | X | Ki Mazindol binding | Ki DA uptake | Selectivity Uptake/Binding |
280 ± 60 | 320 ± 10 | 1.1 | |||
10400 ± 300 | 13800 ± 1500 | 1.3 | |||
- | - | - | - | - | |
225a | 2β, 6β-OCH3 | 98000 ± 12000 | 68000 ± 5000 | 0.7 | |
225b | 2α, 6β-OCH3 | 190000 ± 11000 | 510000 ± 110000 | 2.7 | |
225c | 2β, 7β-OCH3 | 4200 ± 100 | 6100 ± 200 | 1.4 | |
225d | 2α, 7β-OCH3 | 45000 ± 5000 | 110000 ± 4000 | 2.4 | |
225e | 2α, 7α-OCH3 | 54000 ± 3000 | 200000 ± 70000 | 3.7 |
3''β''-position 2′—(6′) & 2''β''-substitution combination analogues
Compound | S. Singh's alphanumeric assignation | 2β-R | C2′-R | IC50 |
- | - | - | - | |
211a | CO2OH | H | 6214 ± 1269 | |
211b | CH2OCOCH3 | H | 2995 ± 223 | |
211c | CONHCH3 | H | >100000 | |
211d | CO2Et | H | 2031 ± 190 | |
211e | CO2-i-Pr | H | 1377 ± 10 | |
211f | CO2Ph | H | 2019 ± 253 | |
211g | CO2CH2Ph | H | 4602 ± 325 | |
211h | 3-phenyl-1,2,4-oxadiazole | H | 3459 ± 60 | |
- | - | - | - | |
211i | CH=CH2 | H | 2165 ± 253 | |
211j | CH2CH3 | H | 2692 ± 486 | |
212 | CO2-i-Pr | HO | 663 ± 70 4507 ± 13ɑ 34838 ± 796b |
- ɑFor displacement of paroxetine
- bFor displacement of nisoxetine
3''β''-Carbamoyl analogues
Compound | S. Singh's alphanumeric assignation | X | IC50 inhibition of Cocaine binding | IC50 inhibition of DA uptake | Selectivity uptake/binding |
70 ± 10 | 210 ± 70 | 3.0 | |||
- | - | - | - | - | |
223a | H | 5600 ± 700 | 52600 ± 3000 | 9.4 | |
223b | 4-NO2 | 1090 ± 250 | 5700 ± 1200 | 5.2 | |
223c | 4-NH2 | 63300 ± 12200 | >100000 | - | |
223d | 4-N3 | 1000 ± 240 | 1180 ± 360 | 1.2 | |
223e | 4-NCS | 260 ± 60 | 490 ± 80 | 1.9 | |
- | - | - | - | - | |
223f | 3-NO2 | 37 ± 10 | 178 ± 23 | 4.8 | |
223g | 3-NH2 | 2070 ± 340 | 23100 ± 900 | 11.1 | |
223h | 3-N3 | 630 ± 150 | 3900 ± 1590 | 6.2 | |
223i | 3-NCS | 960 ± 210 | 4900 ± 420 | 5.1 |
Phenyl 3-position linkage substitutions
: A structural analogue of cocaine with omitted -COO- linkage – a parent compound of many MAT ligands; those of the phenyltropane class.
See: List of phenyltropanes
The difference in the length of the benzoyloxy and the phenyl linkage contrasted between cocaine and phenyltropanes makes for a shorter distance between the centroid of the aromatic benzene and the bridge nitrogen of the tropane in the latter PTs. This distance being on a scale of 5.6 Å for phenyltropanes and 7.7 Å for cocaine or analogs with the benzoyloxy intact. This may account for PTs increased behavioral stimulation profile over cocaine. Differences in binding potency have also been explained considering solvation effects; cocaine containing 2β,3β-ester groups being calculated as more solvated than the WIN-type compounds. Higher pKɑs of the tropane nitrogen, decreased aqueous solvation & decreased conformational flexibility added to increased binding affinity.
Despite the observation of increased stimulation, phenyltropanes lack the local anesthetic sodium channel blocking effect that the benzoyloxy imparts to cocaine. Beside topical affect, this gives cocaine an affinity for binding to sites on the dopamine and serotonin sodium dependent transport areas that are distinct & specific to MAT in contrast to the general sodium channels; creating a separate mechanism of relational affinity to the transporters in addition to its inhibition of the reuptake for those transporters; this is unique to the local anesthetic value in cocaine & analogues with a similar substitute for the benzoyloxy that leaves the sodium channel blockage ability intact. Rendering such compounds as different functionally in their relation to MAT contrasted to phenyltropane analogues which have the local anesthetic bridge removed.. In addition, it even has been postulated that a crucial role regarding the electron energy imparted via voltage sensitization upon a receptor binding site may attenuate the mediating influence of the inhibitory regulation that autoreceptors play by their slowing neurotransmitter release when an efflux is created through an instance of agonism by a compound; allowing said efflux to be continued without the body's attempt to maintain homeostasis enacting in as readily responsive a manner to its conformational change.
3''β''-Alkylphenyltropane & 3''β''-Alkenyl analogues
The compound 224e, the 3β-styrene analogue, had the highest potency in its group. While 224b & 224c showed the most selectivity, with 224b having a ten-fold greater potency for the dopamine transporter than cocaine.Compound | S. Singh's alphanumeric assignation | n | IC50 Cocaine binding | IC50 DA uptake | Selectivity uptake/binding |
101 ± 26 | 209 ± 20 | 2.1 | |||
- | - | - | - | - | |
224a | 1 | 885 ± 18 | 1020 ± 52 | 1.1 | |
224b | 2 | 9.9 ± 0.33 | 70.5 ± 1.0 | 7.1 | |
224c | 3 | 344 ± 12 | 2680 ± 190 | 7.8 | |
224d | 71.6 ± 0.7 | 138 ± 9 | 1.9 | ||
224e | 2.10 ± 0.04 | 5.88 ± 0.09 | 2.8 |
6-Alkyl-3-benzyltropane analogues
Compound | S. Singh's alphanumeric assignation | R | Ki WIN 35428 binding | IC50 DA uptake | Selectivity uptake/binding |
32 ± 5 338 ± 221 | 405 ± 91 405 ± 91 | 12.6 1.2 | |||
11a | 33 ± 17 314 ± 222 | 373 ± 10 | 11.3 | ||
- | - | - | - | - | |
-229a | H | 33 ± 5 | 161 ± 100 | 4.9 | |
229a | H | 91 ± 10 | 94 ± 26 | 1.0 | |
229b | Me | 211 ± 23 | - | - | |
229c | Et | 307 ± 28 | - | - | |
229d | n-Pr | 4180 ± 418 | - | - | |
229e | n-Bu | 8580 ± 249 | - | - | |
229f | Bn | 3080 ± 277 | - | - | |
- | - | - | - | - | |
-230a | H | 60 ± 6 | 208 ± 63 | 3.5 | |
230a | H | 108 ± 14 | 457 ± 104 | 4.2 | |
230b | Me | 561 ± 64 | - | - | |
230c | Et | 1150 ± 135 | - | - | |
230d | n-Pr | 7240 ± 376 | - | - | |
230e | n-Bu | 19700 ± 350 | - | - | |
230f | Bn | 7590 ± 53 | - | - | |
- | - | - | - | - | |
231b | Me | 57 ± 5 | 107 ± 36 | 1.9 | |
231c | Et | 3110 ± 187 | - | - | |
231d | n-Pr | 5850 ± 702 | - | - | |
231f | Bn | 1560 ± 63 | - | - | |
- | - | - | - | - | |
232b | Me | 294 ± 29 | 532 ± 136 | 1.8 | |
232c | Et | 6210 ± 435 | - | - | |
232d | n-Pr | 57300 ± 3440 | - | - | |
232f | Bn | 3080 ± 277 | - | - | |
241 | Bn | 4830 ± 434 | - | - |
Sub-category | a R=H | b R=Me | c R=Et | d R=n-Pr | e R=n-Bu | f R=Bn |
6α-isomers: 237a—f | - | - | - | - | - | - |
6α-isomers: 237a—f | ||||||
6β-isomers : 238a—f | - | - | - | - | - | - |
6β-isomers : 238a—f | ||||||
3β-benzyl derivatives: 239a—f | - | - | - | - | - | - |
3β-benzyl derivatives: 239a—f | ||||||
intermediate alkylidene esters: 240a—f | - | - | - | - | - | - |
intermediate alkylidene esters: 240a—f |
N.B. that 237a and 238a are the same compound as both are the parent for either series with a hydrogen saturated in their respective substitution place.
Direct 2,3-pyrimidino fused
cf. strobamine for a more efficacious compound as like the below.Structure | alphanumeric assignation | R1 | R2 | hDAT IC50 | hSERT IC50 | hNET IC50 |
- | - | - | - | - | - | |
-3a | H | C6H5 | 58,300 | 6140 | NA | |
-3a | H | C6H5 | 48,700 | 6030 | NA | |
- | - | - | - | - | - | |
-3b | H | NH2 | NA | NA | NA | |
-3b | H | NH2 | NA | NA | NA | |
- | - | - | - | - | - | |
-3c | H | CH3 | NA | NA | NA | |
-3c | H | CH3 | NA | NA | NA | |
- | - | - | - | - | - | |
-3d | H | H | NA | NA | NA | |
-3d | H | H | NA | NA | NA | |
-3e | C6H5 | C6H5 | 30,000 | 3650 | NA |
- "NA" = "no affinity", e.g. unquantifiable.
Piperidine cocaine-homologues
cf. phenyltropane piperidine-homologues for compounds with a more optimized conformation that yield higher affinities when binding to MAT.Compound | S. Singh's alphanumeric assignation | 2β-R | IC50 |
CO2CH3 | 249 ± 37 | ||
183a | CO2CH3 | 2522 ± 4 | |
- | - | - | |
242 | H | 11589 ± 4 | |
243 | CO2CH3 | 8064 ± 4 |
Cocaine [hapten] analogues
Compound | S. Singh's alphanumeric assignation | 2β-R |
394 ɑ | CO25CO2H | |
395 | CO2CH3 | |
GNEb including carrier proteins: GNE-FLiC GNE-KLH GNE-BSA | ||
396 | CONH5CO2H |
- ɑ6--3--8-methyl-8-azabicyclo
octane-2-carbonyloxy-hexanoic acid - b6--3--8-methyl-8-azabicyclo
octane-2-carboxamido-hexanoic acid
Compound | S. Singh's alphanumeric assignation | R |
- | - | |
401a | CH3 | |
401b | 5CO2H | |
401c | CH2CO2H | |
401d | COCH2CH2CO2H | |
401e | H | |
401f | CH2CH2Br | |
385g | 2NHCO2CONH2 | |
- | - | |
402a | O4NHCO2CO2...2,3-dihydro-1H-isoindole-1,3-dione | |
402b | OH | |
402c | O2...1,4-xylene...NH2 | |
402d | NH5CO2H | |
402e | O4NHCO2CONH2 | |
- | - | |
403a | NH2 | |
403b | NHCOCH2Br | |
403c | NHCO3CO2H | |
403d | 3NHCO2CONH2 |
Cocaine haptens that create catalytic anti-bodies require transitional states as affected in vivo.
Compound | Name |
- | |
K1-KLH/BSA | |
- | |
K2-KLH/BSA |
Structural/Functional intermediate analogues
Piperidine Analogues
A somewhat recent occurrence among tentative modern folklore which has traversed the circling of rumors mostly confined to the likes of universities and popular culture trivia has been that cocaine is one element, or molecule increment of weight or charge etc., away from the molecular structure of sugar. Though such a statement is false as a general pretense, there is a dextrose based super-structure that has a vaguely similar overlay with cocaine which is "benzoyl-beta-D-glucoside."- Benzoyl-beta-D-glucoside
Benztropine (3α-Diphenylmethoxy Tropane) Analogs
- Benzatropine
- Difluoropine, More selective as a DARI than cocaine. Also an anticholinergic & antihistamine.
- AHN 1-055 Same structure as for benztropine but 4′,4′-bisfluorinated.
- GA 103 N-phenylpropyl bis-4-fluorobenztropine.
- JHW 007 N--3α--tropane.
"Difluoropine" is not a phenyltropane but actually belongs to the benzatropine family of DRIs. Not to be confused for the "diaryl"-phenyltropanes.
In certain respects these are important because they share SAR overlap with GBR 12909 and related analogs.
SARs have shown that 4′,4′-difluorination is an excellent way to boost DAT activity of benztropine, and gives excellent selectivity over the SERT and the NET.
Furthermore, replacing the N-Me with, e.g. n-phenylpropyl helps to bring muscarinic activity down to something that is the same as DRI affinity.
This is remarkable considering unmodified benztropine is 60 times more active as an anticholinergic than as a dopaminergic.
M1 receptor considerations aside, analogues of this benztropine class still won't substitute for cocaine, and have no propensity to elevate locomotor activity.
Compound | S. Singh's alphanumeric assignation | R | R′ | Ki WIN 35428 binding | IC50 DA uptake | Selectivity uptake/binding |
388 ± 47 | - | - | ||||
11.6 ± 31 | - | - | ||||
- | - | - | - | - | - | |
H | H | 118 ± 9 | 403 ± 115 | 3.4 | ||
249a | 4′-F | H | 32.2 ± 10 | 48 | 1.5 | |
249b | 4′-F | 4′-F | 11.8 ± 1 | 71 | 6.0 | |
249c | 3′,4′-di-F | H | 27.9 ± 11 | 181 ± 45.7 | 6.5 | |
249d | 4′-Cl | H | 30.0 ± 12 | 115 | 3.8 | |
249e | 4′-Cl | 4′-Cl | 20.0 ± 14 | 75 | 3.8 | |
249f | 3′,4′-di-Cl | H | 21.1 ± 19 | 47 | 2.2 | |
249g | 3′,4′-di-Cl | F | 18.9 ± 14 | 24 | 1.3 | |
249h | 4′-Br | H | 37.9 ± 7 | 29 | 0.8 | |
249i | 4′-Br | 4′-Br | 91.6 | 34 | 0.4 | |
249j | 4′-NO2 | H | 197 ± 8 | 219 | 1.1 | |
249k | 4′-CN | H | 196 ± 9 | 222 | 1.1 | |
249l | 4′-CF3 | H | 635 ± 10 | 2155 | 3.4 | |
249m | 4′-OH | H | 297 ± 13 | 677 | 2.3 | |
249n | 4′-OMe | H | 78.4 ± 8 | 468 | 6.0 | |
249o | 4′-OMe | 4′-OMe | 2000 ± 7 | 2876 | 1.4 | |
249p | 4′-Me | H | 187 ± 5 | 512 | 2.7 | |
249q | 4′-Me | 4′-Me | 420 ± 7 | 2536 | 6.0 | |
249r | 4′-Et | H | 520 ± 8 | 984 | 1.9 | |
249s | 4′-t-Bu | H | 1918 | 4456 | 2.3 | |
250a | 3′-F | H | 68.5 ± 12 | 250 ± 64.7 | 3.6 | |
250b | 3′-F | 3′-F | 47.4 ± 1 | 407 ± 63.9 | 8.6 | |
250c | 3′-Cl | H | 21.6 ± 7 | 228 ± 77.1 | 10.5 | |
250d | 3′-CF3 | H | 187 ± 5 | 457 ± 72.0 | 2.4 | |
251a | 2′-F | H | 50.0 ± 12 | 140 ± 17.2 | 2.8 | |
251b | 2′-Cl | H | 228 ± 9 | 997 ± 109 | 4.4 | |
251c | 2′-Me | H | 309 ± 6 | 1200 ± 1.64 | 3.9 | |
251d | 2′-NH2 | H | 840 ± 8 | 373 ± 117 | 0.4 |
Compound | S. Singh's alphanumeric assignation | R | n | IC50 DAT | IC50 5-HTT | Selectivity 5-HTT/DAT |
- | - | - | - | - | - | |
258a | 20.3 ± 3.5 | - | - | |||
258b | H | 1 | 223 ± 53 | 4970 ± 700 | 22.3 | |
258c | H | 3 | 22.0 ± 11.9 | 19.7 ± 3 | 0.9 | |
258d | Br | 3 | 80.2 ± 8.8 | 234 ± 0.5 | 2.9 | |
258e | I | 3 | 119 ± 11 | 2200 ± 1250 | 18.5 | |
258f | H | 5 | 99.0 ± 28 | 550 ± 63 | 5.5 | |
259 | 616 ± 88 | 55200 ± 20000 | 89.3 |
Compound | S. Singh's alphanumeric assignation | R | Ki DAT | IC50 5-HTT | Selectivity uptake/binding |
- | - | - | - | - | |
260 | H | 11.2 ± 11 | 9.7 | 0.9 | |
261a | 3-phenylpropyl | 41.9 ± 11 | 230 | 5.5 | |
261b | indole-3-ethyl | 44.6 ± 11 | 1200 | 26.9 | |
261c | 4-phenylbutyl | 8.51 ± 14 | 39 | 4.6 | |
261d | 4-butyl | 20.2 ± 11 | 650 | 32.2 | |
261e | 3-propyl | 60.7 ± 12 | - | - | |
262a | n-butyl | 24.6 ± 8 | 370 | 15.0 | |
262b | cyclopropylmethyl | 32.4 ± 9 | 180 | 5.5 | |
262c | allyl | 29.9 ± 10 | 14 | 0.5 | |
262d | benzyl | 82.2 ± 15 | 290 | 3.5 | |
262e | 4-fluorobenzyl | 95.6 ± 10 | 200 | 2.1 | |
262f | cinnanyl | 86.4 ± 12 | 180 | 2.1 | |
262g | ethyl | 634 ± 23 | - | - | |
262h | ethyl | 57.0 ± 17 | - | - | |
263 | acetyl | 2340 | 4600 | 2.0 | |
264 | formyl | 2020 ± 13 | 5400 | 2.7 | |
265a | Ts | 0%ɑ | - | - | |
265b | Ms | 18%ɑ | - | - | |
CH2CH=CH2 | - | - | - | ||
CH2CH2CH2CH3 | - | - | - | ||
CH2CH2NH2 | - | - | - | ||
CH2CH2CH2CH2Ph | - | - | - | ||
266 | 108 ± 12 | 130 | 1.2 |
ɑInhibition at 10 μM
; a di-para-fluoro benztropine, and hybrid between benzatropine & difluoropine.
Compound | S. Singh's alphanumeric assignation | IC50 DAT | IC50 5-HTT | |
R/S-268 | 2β,3β | >10000 | >1660 | |
R/S-269 | 2α,3β | 20300 | >1660 | |
R/S-270 | 2α,3α | 22300 | >1660 | |
R/S-271 | 2β,3α | 520 | >1660 |
Tropanyl Isoxazoline Analogues
Compound | Name | - | - | - |
- | ||||
- | 4a | 4c | 5a | 5c |
- | ||||
- | 6a | 6b | 6c | 7a |
- | ||||
- | 7b | 7c | 8a | 8b |
- | ||||
- | 8c | 9a | 9b | 9c |
- | - | |||
- | 9c | 10a | 10b | 10c |
- | ||||
- | 11a | 11b | 12a | 12b |
8-Aminopentacyclo (σ receptor ligand) [Trishomocubane] Analogs
cf. other trishomocubanes such as basketane.Sigma receptor agonists with nanomolar affinity such as CM156 have been shown to counteract the deleterious effects of cocaine when co-administered with it. Indicative that e.g. the local anesthetic effect at the sigma site mediating the toxicity or otherwise a cross over or tie in of cocaine's separate functionalities lowering threshold to its safety profile.
Polycyclic cage molecules: N-substituted 8-aminopentacycloundecanes & related.
The 3-FPh, 14b, has 1.2 ± 0.1 Ki @ DAT.
Bicyclic Amine Analogues
Quinuclidine Analogues
Dihydroimidazoles
See: List of Mazindol analoguesMazindol is usually considered a non-habituating tetracyclic dopamine reuptake inhibitor.
It is a loosely functional analog used in cocaine research; due in large part to N-Ethylmaleimide being able to inhibit approximately 95% of the specific binding of Mazindol to the residues of the MAT binding site, however said effect of 10 mM N-Ethylmaleimide was prevented in its entirety by just 10 μM cocaine. Whereas neither 300 μM dopamine or D-amphetamine afforded sufficient protection to contrast the efficacy of cocaine.
The above steps in its synthesis show the similitude of its precursors to the MAT reuptake inhibitor pipradrol & related compounds.
Local anesthetics (not usually CNS stimulants)
In animal studies, certain of the local anesthetics have displayed residual dopamine reuptake inhibitor properties, although not normally ones that are easily available. These are expected to be more cardiotoxic than phenyltropanes. For example, dimethocaine has behavioral stimulant effects if a dose of it is taken that is 10 times the amount of cocaine. Dimethocaine is equipotent to cocaine in terms of its anesthetic equivalency. has been shown to reverse the cardiotoxic effects of sodium channel blockers and presumably those effects when from cocaine administered intravenously as well.Name | Other common names |
Amylocaine | Stovaine |
Articaine | Astracaine, Septanest, Septocaine, Ultracaine, Zorcaine |
Benzocaine | |
Bupivacaine | Marcaine, Sensorcaine, Vivacaine |
Butacaine | |
Carticaine | |
Chloroprocaine | Nesacaine |
Cinchocaine/Dibucaine | Cincain, Cinchocaine, Nupercainal, Nupercaine, Sovcaine |
Cyclomethycaine | Surfacaine, Topocaine |
Etidocaine | |
Eucaine | α-eucaine, β-eucaine |
Fomocaine | |
Fotocaine | |
Hexylcaine | Cyclaine, Osmocaine |
Levobupivacaine | Chirocaine |
Lidocaine/Lignocaine | Xylocaine, Betacaine |
Mepivacaine | Carbocaine, Polocaine |
Meprylcaine/Oracaine | Epirocain |
Metabutoxycaine | Primacaine |
Phenacaine/Holocaine | |
Piperocaine | Metycaine |
Pramocaine/Pramoxine | |
Prilocaine | Citanest |
Propoxycaine/Ravocaine | |
Procaine/Novocaine | Borocaine, Ethocaine |
Proparacaine/Alcaine | |
Quinisocaine | Dimethisoquin |
Risocaine | |
Ropivacaine | Naropin |
Tetracaine/Amethocaine | Pontocaine, Dicaine |
Trimecaine | Mesdicain, Mesocain, Mesokain |